<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="26600">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01723215</url>
  </required_header>
  <id_info>
    <org_study_id>TelAvivU</org_study_id>
    <nct_id>NCT01723215</nct_id>
  </id_info>
  <brief_title>Prevention of Combat-related PTSD Using Attention Bias Modification (ABM): A Randomized Controlled Trial</brief_title>
  <official_title>Prevention of Posttraumatic Symptoms in IDF Soldiers Using Attention Bias Modification (ABM): A Randomized Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Tel Aviv University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Medical Corps, Israel Defense Force</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Walter Reed Army Institute of Research (WRAIR)</agency>
      <agency_class>U.S. Fed</agency_class>
    </collaborator>
  </sponsors>
  <source>Tel Aviv University</source>
  <oversight_info>
    <authority>Israel: Ministry of Health</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Military deployment to combat zones involves exposure to trauma at a higher than average
      rate and therefore presents a unique opportunity to study predisposing factors to
      posttraumatic stress reactions and test strategies designed to prevent and ameliorate
      posttraumatic symptoms. Decades of scientific research on the origins of resilience and
      vulnerability to combat-related posttraumatic stress symptoms revealed various predisposing
      and protective factors. All these factors however, offer limited opportunity for systematic
      pre-deployment prevention efforts. Considering the magnitude of psychological adjustment
      difficulties encountered by combat personnel in deployment and the limited access to
      existing evidence-based therapies for PTSD, the development and testing of a novel
      evidence-based and theory-driven prevention protocol for these problems is of considerable
      significance. The current study translates cognitive-neuroscience knowledge and attention
      bias modification research into a novel computerized training tool that could be easily
      delivered to soldiers during different stages of the deployment cycle. If proved efficacious
      in reducing risk for posttraumatic symptoms ABMT could be integrated into the Army's
      resilience training program. Thus, we propose a longitudinal double-blind randomized
      controlled study of ABMT in soldiers. We will assess attention bias and symptoms before
      deployment, will randomly assign soldiers to either 8 ABMT sessions, 4 ABMT sessions, 8
      Placebo training sessions, or no training. Following 6 months of deployment to combat zone
      symptoms will be assessed again.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>December 2012</start_date>
  <completion_date type="Anticipated">August 2014</completion_date>
  <primary_completion_date type="Anticipated">August 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Intervention Model: Factorial Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Prevention</study_design>
  <primary_outcome>
    <measure>PTSD Checklist (PCL)- PTSD symptoms</measure>
    <time_frame>Pre-traetment baseline and in deployment</time_frame>
    <safety_issue>No</safety_issue>
    <description>PCL will be collected twice:
Before ABM and before deployment
In combat zone after 6 months deployment</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>PHQ-9 (Depression), STAI (Anxiety)</measure>
    <time_frame>Pre-traetment baseline and in deployment</time_frame>
    <safety_issue>No</safety_issue>
    <description>PHQ-9 and STAI will be collected twice:
Before ABM and before deployment
In combat zone after 6 months deployment</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Attention Bias Scores</measure>
    <time_frame>Pre-traetment baseline and in deployment</time_frame>
    <safety_issue>No</safety_issue>
    <description>Attention bias scores measured in milliseconds using the dot-probe task</description>
  </other_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Anticipated">720</enrollment>
  <condition>PTSD</condition>
  <arm_group>
    <arm_group_label>Active ABMT8</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Active ABMT8 8 active ABMT sessions (10 min. each, over 7-8 weeks) designed to promote adaptive threat attendance</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Active ABMT4</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Active ABMT4 4 active ABMT sessions (10 min. each, over 7-8 weeks) designed to promote adaptive threat attendance</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Control: will not receive any intervention</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Placebo: will receive 4 training sessions(10 min. each, over 7-8 weeks) using the same task and stimuli as in the active arms, but not designed to change attention patterns</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Active ABMT8</intervention_name>
    <description>Active ABMT8 8 active ABMT sessions (10 min. each, over 7-8 weeks) designed to promote adaptive threat attendance</description>
    <arm_group_label>Active ABMT8</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Active ABMT4</intervention_name>
    <description>Active ABMT4 4 active ABMT sessions (10 min. each, over 7-8 weeks) designed to promote adaptive threat attendance</description>
    <arm_group_label>Active ABMT4</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>Placebo: will receive 4 training sessions(10 min. each, over 7-8 weeks) using the same task and stimuli as in the active arms, but not designed to change attention patterns</description>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  combat soldiers

        Exclusion Criteria:

          -  Fluent Hebrew
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>28 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Yair Bar-Haim, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Tel Aviv University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Eyal Fruchter</last_name>
    <role>Principal Investigator</role>
    <affiliation>Mental Health Department IDF</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Yair Bar-Haim, PhD</last_name>
    <phone>972-3-6405465</phone>
    <email>yair1@post.tau.ac.il</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Ilan Wald, M.A.</last_name>
    <phone>972-36405465</phone>
    <email>ilanwald@013net.net</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>IDF Military camps</name>
      <address>
        <city>Beer sheva</city>
        <country>Israel</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Yair Bar-Haim, PhD</last_name>
      <phone>972-36405465</phone>
      <email>yair1@post.tau.ac.il</email>
    </contact>
    <investigator>
      <last_name>Eyal Fruchter, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Israel</country>
  </location_countries>
  <reference>
    <citation>Bar-Haim Y. Research review: Attention bias modification (ABM): a novel treatment for anxiety disorders. J Child Psychol Psychiatry. 2010 Aug;51(8):859-70. doi: 10.1111/j.1469-7610.2010.02251.x. Epub 2010 May 6. Review.</citation>
    <PMID>20456540</PMID>
  </reference>
  <reference>
    <citation>Bar-Haim Y, Holoshitz Y, Eldar S, Frenkel TI, Muller D, Charney DS, Pine DS, Fox NA, Wald I. Life-threatening danger and suppression of attention bias to threat. Am J Psychiatry. 2010 Jun;167(6):694-8. doi: 10.1176/appi.ajp.2009.09070956. Epub 2010 Apr 15.</citation>
    <PMID>20395400</PMID>
  </reference>
  <verification_date>June 2013</verification_date>
  <lastchanged_date>June 5, 2013</lastchanged_date>
  <firstreceived_date>November 5, 2012</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Tel Aviv University</investigator_affiliation>
    <investigator_full_name>Yair Bar-Haim</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <keyword>Attention bias modification</keyword>
  <keyword>resilience</keyword>
  <keyword>combat</keyword>
  <keyword>PTSD</keyword>
  <keyword>Depression</keyword>
  <keyword>Anxiety</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Stress Disorders, Post-Traumatic</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
